Armin Schulz
Born in Mönchengladbach, he studied business administration in the Netherlands. In the course of his studies he came into contact with the stock exchange for the first time. He has more than 25 years of experience in stock market business.
After graduating, he worked as an IT consultant for a listed company before becoming self-employed, during which time he worked for various DAX-listed companies and a large Swiss insurance company, among others.
Since 2009, he has been exclusively involved in the capital markets, where he was able to gain experience as a day and swing trader, in investor relations and at board level. He was able to live out his passion for numbers in the controlling department of a securities trading house.
For him, fundamental analysis paired with the correct reading of the price action of a market provides the basis for successful trading.
Commented by Armin Schulz
Commented by Armin Schulz on June 27th, 2022 | 13:39 CEST
SAP, Kleos Space, RWE - Crisis-resistant stocks that belong in the portfolio
Even though the mood on the markets has brightened somewhat in the past week, the Fear and Greed Index rose from 14 to 18, so the uncertainty on the markets is still palpable. One must pick companies whose business models will work well in the long run. These companies have also suffered setbacks from the current market environment but are well prepared for the challenges ahead. We have picked three companies that should benefit from the tough times ahead.
Read
Commented by Armin Schulz on June 24th, 2022 | 10:15 CEST
Commerzbank, Triumph Gold, Bitcoin Group - Inflation alert! Which stocks bring returns in this market environment?
We have not seen such high inflation for decades. Looking back, it becomes clear that one cannot compare the situation back then with today. Back then, interest rates were at 12%, and as a saver, you could generate an increase in value for your money despite inflation. Today, interest rates are much lower than inflation. Putting money in a savings account will not bring any investor a profit. If you want to protect your money, the first thing that comes to mind is gold because it is considered crisis-proof. But nowadays, it almost seems as if cryptocurrencies could outperform gold. Alternatively, one can bet on stocks that cover these areas. We take a closer look at three companies.
Read
Commented by Armin Schulz on June 22nd, 2022 | 10:14 CEST
TUI, Barsele Minerals, Steinhoff - Which share will manage the turnaround?
Times are currently difficult on the stock market, as there is a lot of uncertainty. On the one hand, there is the question of how long the Ukraine conflict will last, and on the other hand, there is high inflation, which the central banks are trying to combat with rising interest rates. But higher interest rates mean less investment, so the fear of recession is palpable. The still ongoing supply chain problems are also causing headaches for investors. Today, we take a look at three companies that have recently fallen foul of the market and analyze which of the candidates can turn things around.
Read
Commented by Armin Schulz on June 20th, 2022 | 10:34 CEST
Varta, Altech Advanced Materials, BYD - Full focus on the battery of the future for e-cars
The farewell to the combustion engine is a done deal. In the future, passenger cars will be powered electrically. The battery is crucial for success. Elon Musk said years ago, "The battery is our biggest bottleneck." It is still true today, as the batteries limit range and charging times remain high. Whoever succeeds in producing a better battery with less weight, longer durability, and faster charging can clearly set themselves apart from the competition. Today, we take a look at three companies that are tackling the development of the e-car battery of the future.
Read
Commented by Armin Schulz on June 17th, 2022 | 10:45 CEST
BioNTech, Defence Therapeutics, Formycon - Biotech stocks with a lot of future potential
A look at the NASDAQ Biotechnology Index shows that the big hype on biotech companies seems to be over for now. Since September 2021, the index has been falling, repeatedly marking new lows. However, this decline can also be seen as an opportunity because the long-term prospects for the industry are good. People are getting older, and with age comes the diseases that want to be fought. Today we look at three companies with a lot of potential for the future.
Read
Commented by Armin Schulz on June 15th, 2022 | 11:45 CEST
K+S, Erin Ventures, Nvidia - Buy high-class shares when the cannons roar
The markets have lost a lot of ground in the past few days. Among them are companies excellently positioned for the future and are among the major players in their respective fields. Warren Buffet follows the maxim: "Be fearful when others are greedy, and be greedy when others are fearful." The Fear and Greed Index stands at 18 on extreme fear. So it is time to get quality into your portfolio. Today we look at three companies that seem promising in the long term.
Read
Commented by Armin Schulz on June 13th, 2022 | 15:45 CEST
Alibaba, Almonty Industries, Shell - Shares with conspicuous strength in the crisis
The past week was tough for many investors. First, the ECB declared on Wednesday to raise interest rates, and on Friday, it was announced that the inflation rate in the US rose to 8.6% in May. As a result of these events, the markets collapsed and a number of blue chips suffered, in some cases significantly. But even in the weak phases, some shares buck the general market trend, which is a clear sign of strength. When the market as a whole turns around, it is precisely these stocks that often benefit disproportionately. We have picked out three companies that have held up well in the falling market environment and look closely at their future prospects.
Read
Commented by Armin Schulz on June 10th, 2022 | 11:48 CEST
BioNTech, NervGen Pharma, Valneva - Which stock will make the breakthrough in incurable diseases?
The number of cancer patients increases every year, and only if the disease is detected at an early stage might a cure still be possible. With other diseases such as multiple sclerosis or Alzheimer's, there is no chance of a cure at all. The deterioration progresses slowly and unstoppably. COVID-19 has also shown us how vulnerable humanity is to a virus. But many biotech companies have taken up the fight against these diseases. Any drug that can stop the progression of these diseases would help those affected. Many biotech stocks have corrected significantly recently. Today we take a look at three companies and their existing potential against incurable diseases.
Read
Commented by Armin Schulz on June 8th, 2022 | 10:45 CEST
BP, Desert Gold, Livent - Gold stocks from different sectors
Why are BP and Livent gold stocks, some readers may ask? The answer is simple, because the gold term is being used for more and more commodities, especially as prices have skyrocketed. Such is the case with oil, the black gold, and lithium, the white gold. "Real" gold, on the other hand, has fallen back to the USD 1850 range after its breakout with the onset of the Ukraine crisis. So which gold should you put your money in now? We take a look at one Company from each sector.
Read
Commented by Armin Schulz on June 3rd, 2022 | 10:49 CEST
Bayer, Globex Mining, RWE - Diversified shares perform strongly in tough times
Going all-in is extremely risky on the stock market. Because in the long run, you are not always right with your estimates, so a poor trade can quickly tear down the good performance. For example, a better approach would be to diversify the portfolio, spreading the investment over 10 different companies. Two big winners are enough to more than absorb several total losses. Those who want even more security can add stocks to their portfolio that are already diversified. Today we will take a closer look at three companies of this kind.
Read